D17G (p.Asp17Gly) variant of MEN1 (Menin)
D17G (p.Asp17Gly) in MEN1 (Menin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome; Multiple endocrine neoplasia, type 1; n. The available variant effect predictions contribute to a CATVariant prioritization score of 0.75 / 1. The record also includes population frequency data, published literature, and structural context.
D17G (p.Asp17Gly) variant details
- p.Asp17Gly
- rs1157581823
- ClinGen CA381188167
- ClinVar RCV001224295
- ClinVar RCV003380903
- Uncertain significance
- Hereditary cancer-predisposing syndrome; Multiple endocrine neoplasia, type 1; n
- Missense
- Variant Prioritization Score for Impact Estimate 0.747
- REVEL 0.85
- CADD 23.90
- PolyPhen-2 0.18
- SIFT 0.26
- ClinVar: Uncertain significance (Hereditary cancer-predisposing syndrome; Multiple endocrine neop)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the Non-Finnish European population (allele frequency 1.5e-05)
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)
- Cited in: Guidelines for diagnosis and therapy of MEN type 1 and type 2. (PMID 11739416)